Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum
- J. Control. Release Feb 11 2025, 380 S0168-3659(25)00114-2 | https://doi.org/10.1016/j.jconrel.2025.02.008